Literature DB >> 27225463

Roles of human apolipoprotein E in the infectivity and replication of hepatitis C virus genotype 2a.

Bo-Kyoung Jung1, Hye-Ran Kim1, Gyu-Nam Park1, Guangxiang Luo2,3,4, Kyung-Soo Chang5.   

Abstract

Hepatitis C virus (HCV) infection is associated with lipoproteins, and apolipoprotein E (apoE) plays an essential role in infectious HCV particles. Although the role of apoE in HCV infection is well known, its role in the replication of HCV remains unclear. The aims of this study were to determine the role of apoE in the RNA replication of major HCV genotypes 1b and 2a, and to determine whether this role is HCVgenotype-dependent using HCV genotype 1b replicon cells and HCV genotype 2a producing (HP) cells. HCV infection was blocked in Huh7.5 cells treated with low-density lipoproteins, very low-density lipoproteins, or apoE3. An apoE3-specific monoclonal antibody also efficiently neutralized HCV infectivity, and HCV infection was dramatically suppressed by the knockdown of apoE expression with an apoE-specific small interfering RNA, suggesting a requirement for apoE in infectious HCV particles. HCV RNA replication was not affected in HP cells treated with each apoE isoform or transfected with apoE-specific siRNAs. However, the knockdown of apoE expression suppressed RNA replication of HCV genotype 1b. The siRNA-mediated knockdown of apoE, apoA1, and apoB expression also suppressed the RNA replication of HCV genotype 1b, but not that of HCV genotype 2a. Taken together, these findings indicate that apoE plays an important role in HCV genotype 2a infection and in HCV genotype 1b RNA replication, but not in the replication of HCV genotype 2a. These results provide important information for the future development of HCV-genotypespecific anti-HCV agents.

Entities:  

Keywords:  apolipoprotein E; genotypes; hepatitis C Virus (HCV); replication; small interfering RNA (siRNA)

Mesh:

Substances:

Year:  2016        PMID: 27225463     DOI: 10.1007/s12275-016-6099-3

Source DB:  PubMed          Journal:  J Microbiol        ISSN: 1225-8873            Impact factor:   3.422


  33 in total

1.  Robust production of infectious hepatitis C virus (HCV) from stably HCV cDNA-transfected human hepatoma cells.

Authors:  Zhaohui Cai; Chen Zhang; Kyung-Soo Chang; Jieyun Jiang; Byung-Chul Ahn; Takaji Wakita; T Jake Liang; Guangxiang Luo
Journal:  J Virol       Date:  2005-11       Impact factor: 5.103

2.  Ultrastructural and biophysical characterization of hepatitis C virus particles produced in cell culture.

Authors:  Pablo Gastaminza; Kelly A Dryden; Bryan Boyd; Malcolm R Wood; Mansun Law; Mark Yeager; Francis V Chisari
Journal:  J Virol       Date:  2010-08-04       Impact factor: 5.103

Review 3.  Hepatitis C viral protein translation: mechanisms and implications in developing antivirals.

Authors:  Brett Hoffman; Qiang Liu
Journal:  Liver Int       Date:  2011-05-05       Impact factor: 5.828

Review 4.  Hepatitis C virus particles and lipoprotein metabolism.

Authors:  Patrice André; Gabriel Perlemuter; Agata Budkowska; Christian Bréchot; Vincent Lotteau
Journal:  Semin Liver Dis       Date:  2005-02       Impact factor: 6.115

Review 5.  Immunopathogenesis of hepatitis C virus infection.

Authors:  A J Freeman; G Marinos; R A Ffrench; A R Lloyd
Journal:  Immunol Cell Biol       Date:  2001-12       Impact factor: 5.126

6.  Cellular determinants of hepatitis C virus assembly, maturation, degradation, and secretion.

Authors:  Pablo Gastaminza; Guofeng Cheng; Stefan Wieland; Jin Zhong; Wei Liao; Francis V Chisari
Journal:  J Virol       Date:  2007-12-12       Impact factor: 5.103

7.  Human apolipoprotein e is required for infectivity and production of hepatitis C virus in cell culture.

Authors:  Kyung-Soo Chang; Jieyun Jiang; Zhaohui Cai; Guangxiang Luo
Journal:  J Virol       Date:  2007-10-03       Impact factor: 5.103

8.  Apolipoprotein E mediates attachment of clinical hepatitis C virus to hepatocytes by binding to cell surface heparan sulfate proteoglycan receptors.

Authors:  Jieyun Jiang; Xianfang Wu; Hengli Tang; Guangxiang Luo
Journal:  PLoS One       Date:  2013-07-02       Impact factor: 3.240

9.  Several Human Liver Cell Expressed Apolipoproteins Complement HCV Virus Production with Varying Efficacy Conferring Differential Specific Infectivity to Released Viruses.

Authors:  Kathrin Hueging; Romy Weller; Mandy Doepke; Gabrielle Vieyres; Daniel Todt; Benno Wölk; Florian W R Vondran; Robert Geffers; Chris Lauber; Lars Kaderali; François Penin; Thomas Pietschmann
Journal:  PLoS One       Date:  2015-07-30       Impact factor: 3.240

10.  Expression of hepatitis C virus proteins in epithelial intestinal cells in vivo.

Authors:  Séverine Deforges; Alexey Evlashev; Magali Perret; Mireille Sodoyer; Stéphane Pouzol; Jean-Yves Scoazec; Bertrand Bonnaud; Olivier Diaz; Glaucia Paranhos-Baccalà; Vincent Lotteau; Patrice André
Journal:  J Gen Virol       Date:  2004-09       Impact factor: 3.891

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.